CDH2 and neoplasm: Therefore, rather than being a generalized good or bad indicator of tumorigenesis, the ARF3–N-cadherin rheostat may be a contextual regulator of tumorigenesis in different tumor types by controlling the homogeneity of N-cadherin turnover across the tumor.